1
|
Opportunities and Limitations of Molecular Methods for Studying Bat-Associated Pathogens. Microorganisms 2022; 10:microorganisms10091875. [PMID: 36144476 PMCID: PMC9502413 DOI: 10.3390/microorganisms10091875] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2022] [Revised: 09/15/2022] [Accepted: 09/16/2022] [Indexed: 01/03/2023] Open
Abstract
Bats have been identified as reservoirs of zoonotic and potentially zoonotic pathogens. Significant progress was made in the field of molecular biology with regard to infectious diseases, especially those that infect more than one species. Molecular methods, sequencing and bioinformatics have recently become irreplaceable tools in emerging infectious diseases research and even outbreak prediction. Modern methods in the molecular biology field have shed more light on the unique relationship between bats and viruses. Here we provide readers with a concise summary of the potential and limitations of molecular methods for studying the ecology of bats and bat-related pathogens and microorganisms.
Collapse
|
2
|
Klein A, Eggerbauer E, Potratz M, Zaeck LM, Calvelage S, Finke S, Müller T, Freuling CM. Comparative pathogenesis of different phylogroup I bat lyssaviruses in a standardized mouse model. PLoS Negl Trop Dis 2022; 16:e0009845. [PMID: 35041652 PMCID: PMC8797209 DOI: 10.1371/journal.pntd.0009845] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2021] [Revised: 01/28/2022] [Accepted: 12/14/2021] [Indexed: 12/24/2022] Open
Abstract
A plethora of bat-associated lyssaviruses potentially capable of causing the fatal disease rabies are known today. Transmitted via infectious saliva, occasionally-reported spillover infections from bats to other mammals demonstrate the permeability of the species-barrier and highlight the zoonotic potential of bat-related lyssaviruses. However, it is still unknown whether and, if so, to what extent, viruses from different lyssavirus species vary in their pathogenic potential. In order to characterize and systematically compare a broader group of lyssavirus isolates for their viral replication kinetics, pathogenicity, and virus release through saliva-associated virus shedding, we used a mouse infection model comprising a low (102 TCID50) and a high (105 TCID50) inoculation dose as well as three different inoculation routes (intramuscular, intranasal, intracranial). Clinical signs, incubation periods, and survival were investigated. Based on the latter two parameters, a novel pathogenicity matrix was introduced to classify lyssavirus isolates. Using a total of 13 isolates from ten different virus species, this pathogenicity index varied within and between virus species. Interestingly, Irkut virus (IRKV) and Bokeloh bat lyssavirus (BBLV) obtained higher pathogenicity scores (1.14 for IRKV and 1.06 for BBLV) compared to rabies virus (RABV) isolates ranging between 0.19 and 0.85. Also, clinical signs differed significantly between RABV and other bat lyssaviruses. Altogether, our findings suggest a high diversity among lyssavirus isolates concerning survival, incubation period, and clinical signs. Virus shedding significantly differed between RABVs and other lyssaviruses. Our results demonstrated that active shedding of infectious virus was exclusively associated with two RABV isolates (92% for RABV-DogA and 67% for RABV-Insectbat), thus providing a potential explanation as to why sustained spillovers are solely attributed to RABVs. Interestingly, 3D imaging of a selected panel of brain samples from bat-associated lyssaviruses demonstrated a significantly increased percentage of infected astrocytes in mice inoculated with IRKV (10.03%; SD±7.39) compared to RABV-Vampbat (2.23%; SD±2.4), and BBLV (0.78%; SD±1.51), while only individual infected cells were identified in mice infected with Duvenhage virus (DUVV). These results corroborate previous studies on RABV that suggest a role of astrocyte infection in the pathogenicity of lyssaviruses. Globally, there are at present 17 different officially recognized lyssavirus species posing a potential threat for human and animal health. Bats have been identified as carriers for the vast majority of those zoonotic viruses, which cause the fatal disease rabies and are transmitted through infectious saliva. The occurrence of sporadic spillover events where lyssaviruses are spread from bats to other mammalian species highlights the importance of studying pathogenicity and virus shedding in regard to a potentially sustained onward cross-species transmission. Therefore, as part of this study, we compared 13 different isolates from ten lyssavirus species in a standardized mouse infection model, focusing on clinical signs, incubation periods, and survival. Based on the latter two, a novel pathogenicity index to classify different lyssavirus species was established. This pathogenicity index varied within and between different lyssavirus species and revealed a higher ranking of other bat-related lyssaviruses in comparison to the tested Rabies virus (RABV) isolates. Altogether, our results demonstrate a high diversity among the investigated isolates concerning pathogenicity and clinical picture. Furthermore, we comparatively analyzed virus shedding via saliva and while there was no indication towards a reduced pathogenicity of bat-associated lyssaviruses as opposed to RABV, shedding was increased in RABV isolates. Additionally, we investigated neuronal cell tropism and revealed that bat lyssaviruses are not only capable of infecting neurons but also astrocytes.
Collapse
Affiliation(s)
- Antonia Klein
- Friedrich-Loeffler-Institut (FLI), Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany
| | - Elisa Eggerbauer
- Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut (FLI), Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany
| | - Madlin Potratz
- Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut (FLI), Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany
| | - Luca M. Zaeck
- Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut (FLI), Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany
| | - Sten Calvelage
- Institute of Diagnostic Virology, Federal Research Institute for Animal Health, Friedrich-Loeffler-Institut (FLI), Greifswald-Insel Riems, Germany
| | - Stefan Finke
- Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut (FLI), Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany
| | - Thomas Müller
- Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut (FLI), Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany
| | - Conrad M. Freuling
- Friedrich-Loeffler-Institut (FLI), Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany
- * E-mail:
| |
Collapse
|
3
|
Folly AJ, Marston DA, Golding M, Shukla S, Wilkie R, Lean FZX, Núñez A, Worledge L, Aegerter J, Banyard AC, Fooks AR, Johnson N, McElhinney LM. Incursion of European Bat Lyssavirus 1 (EBLV-1) in Serotine Bats in the United Kingdom. Viruses 2021; 13:v13101979. [PMID: 34696409 PMCID: PMC8536961 DOI: 10.3390/v13101979] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2021] [Revised: 09/29/2021] [Accepted: 09/29/2021] [Indexed: 11/16/2022] Open
Abstract
Lyssaviruses are an important genus of zoonotic viruses which cause the disease rabies. The United Kingdom is free of classical rabies (RABV). However, bat rabies due to European bat lyssavirus 2 (EBLV-2), has been detected in Daubenton’s bats (Myotis daubentonii) in Great Britain since 1996, including a fatal human case in Scotland in 2002. Across Europe, European bat lyssavirus 1 (EBLV-1) is commonly associated with serotine bats (Eptesicus serotinus). Despite the presence of serotine bats across large parts of southern England, EBLV-1 had not previously been detected in this population. However, in 2018, EBLV-1 was detected through passive surveillance in a serotine bat from Dorset, England, using a combination of fluorescent antibody test, reverse transcription-PCR, Sanger sequencing and immunohistochemical analysis. Subsequent EBLV-1 positive serotine bats have been identified in South West England, again through passive surveillance, during 2018, 2019 and 2020. Here, we confirm details of seven cases of EBLV-1 and present similarities in genetic sequence indicating that emergence of EBLV-1 is likely to be recent, potentially associated with the natural movement of bats from the near continent
Collapse
Affiliation(s)
- Arran J. Folly
- Virology Department, Animal and Plant Health Agency, Woodham Lane, Addlestone KT15 3NB, UK; (D.A.M.); (M.G.); (S.S.); (R.W.); (A.C.B.); (A.R.F.); (N.J.); (L.M.M.)
- Correspondence:
| | - Denise A. Marston
- Virology Department, Animal and Plant Health Agency, Woodham Lane, Addlestone KT15 3NB, UK; (D.A.M.); (M.G.); (S.S.); (R.W.); (A.C.B.); (A.R.F.); (N.J.); (L.M.M.)
| | - Megan Golding
- Virology Department, Animal and Plant Health Agency, Woodham Lane, Addlestone KT15 3NB, UK; (D.A.M.); (M.G.); (S.S.); (R.W.); (A.C.B.); (A.R.F.); (N.J.); (L.M.M.)
| | - Shweta Shukla
- Virology Department, Animal and Plant Health Agency, Woodham Lane, Addlestone KT15 3NB, UK; (D.A.M.); (M.G.); (S.S.); (R.W.); (A.C.B.); (A.R.F.); (N.J.); (L.M.M.)
| | - Rebekah Wilkie
- Virology Department, Animal and Plant Health Agency, Woodham Lane, Addlestone KT15 3NB, UK; (D.A.M.); (M.G.); (S.S.); (R.W.); (A.C.B.); (A.R.F.); (N.J.); (L.M.M.)
| | - Fabian Z. X. Lean
- Pathology and Animal Sciences Department, Animal and Plant Health Agency, Addlestone KT15 3NB, UK; (F.Z.X.L.); (A.N.)
| | - Alejandro Núñez
- Pathology and Animal Sciences Department, Animal and Plant Health Agency, Addlestone KT15 3NB, UK; (F.Z.X.L.); (A.N.)
| | - Lisa Worledge
- Bat Conservation Trust, Studio 15 Cloisters House, Cloisters Business Centre, 8 Battersea Park Road, London SW8 4BG, UK;
| | - James Aegerter
- National Wildlife Management Centre, Animal and Plant Health Agency, Sand Hutton, York YO41 1LZ, UK;
| | - Ashley C. Banyard
- Virology Department, Animal and Plant Health Agency, Woodham Lane, Addlestone KT15 3NB, UK; (D.A.M.); (M.G.); (S.S.); (R.W.); (A.C.B.); (A.R.F.); (N.J.); (L.M.M.)
| | - Anthony R. Fooks
- Virology Department, Animal and Plant Health Agency, Woodham Lane, Addlestone KT15 3NB, UK; (D.A.M.); (M.G.); (S.S.); (R.W.); (A.C.B.); (A.R.F.); (N.J.); (L.M.M.)
| | - Nicholas Johnson
- Virology Department, Animal and Plant Health Agency, Woodham Lane, Addlestone KT15 3NB, UK; (D.A.M.); (M.G.); (S.S.); (R.W.); (A.C.B.); (A.R.F.); (N.J.); (L.M.M.)
| | - Lorraine M. McElhinney
- Virology Department, Animal and Plant Health Agency, Woodham Lane, Addlestone KT15 3NB, UK; (D.A.M.); (M.G.); (S.S.); (R.W.); (A.C.B.); (A.R.F.); (N.J.); (L.M.M.)
| |
Collapse
|
4
|
Mechanisms for lyssavirus persistence in non-synanthropic bats in Europe: insights from a modeling study. Sci Rep 2019; 9:537. [PMID: 30679459 PMCID: PMC6345892 DOI: 10.1038/s41598-018-36485-y] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2018] [Accepted: 11/16/2018] [Indexed: 12/25/2022] Open
Abstract
Bats are natural reservoirs of the largest proportion of viral zoonoses among mammals, thus understanding the conditions for pathogen persistence in bats is essential to reduce human risk. Focusing on the European Bat Lyssavirus subtype 1 (EBLV-1), causing rabies disease, we develop a data-driven spatially explicit metapopulation model to investigate EBLV-1 persistence in Myotis myotis and Miniopterus schreibersii bat species in Catalonia. We find that persistence relies on host spatial structure through the migratory nature of M. schreibersii, on cross-species mixing with M. myotis, and on survival of infected animals followed by temporary immunity. The virus would not persist in the single colony of M. myotis. Our study provides for the first time epidemiological estimates for EBLV-1 progression in M. schreibersii. Our approach can be readily adapted to other zoonoses of public health concern where long-range migration and habitat sharing may play an important role.
Collapse
|
5
|
Fuoco NL, Fernandes ER, Dos Ramos Silva S, Luiz FG, Ribeiro OG, Santos Katz IS. Street rabies virus strains associated with insectivorous bats are less pathogenic than strains isolated from other reservoirs. Antiviral Res 2018; 160:94-100. [PMID: 30393124 DOI: 10.1016/j.antiviral.2018.10.023] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2018] [Revised: 10/16/2018] [Accepted: 10/25/2018] [Indexed: 01/08/2023]
Abstract
Rabies is a fatal and viral zoonosis that causes acute, progressive encephalitis and remains an important concern in public health. In the last few years, there has been a change in the epidemiological profile of rabies after implementing canine rabies control in the Americas, which has led to a significant increase in both human and pet cases of rabies associated with insectivorous bats. Thus, it is important to understand the pathogenesis caused by Rabies virus (RABV) isolates from insectivorous bats. Viral growth kinetics, cell-to-cell spread and virus uptake in vitro were analyzed for RABV isolates from Eptesicus furiralis and Myotis nigricans. For pathogenesis evaluation, mice were inoculated with RABV isolates from Eptesicus furiralis and Myotis nigricans, and clinical signs were observed for 40 days. We observed that the insectivorous bat strains showed a higher replication rate, faster cell-to-cell spread and delayed virus uptake in N2a cells. Furthermore, after the first sign of a clinical infection, mice infected with Myotis nigricans and Eptesicus furiralis isolates succumbed rapidly (6 ± 9 days) compared with RABV strains associated with other reservoirs. Our results show that the insectivorous bat RABV strains are less pathogenic for mice than strains associated with other reservoirs. In addition, this study also indicates that the differences in the biological characteristics of the RABV strains are important to their pathogenicity. An enhanced understanding of rabies pathogenesis may be important for the development of novel therapies for humans and in the implementation of rabies control strategies.
Collapse
|
6
|
Robardet E, Borel C, Moinet M, Jouan D, Wasniewski M, Barrat J, Boué F, Montchâtre-Leroy E, Servat A, Gimenez O, Cliquet F, Picard-Meyer E. Longitudinal survey of two serotine bat (Eptesicus serotinus) maternity colonies exposed to EBLV-1 (European Bat Lyssavirus type 1): Assessment of survival and serological status variations using capture-recapture models. PLoS Negl Trop Dis 2017; 11:e0006048. [PMID: 29149215 PMCID: PMC5693283 DOI: 10.1371/journal.pntd.0006048] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2017] [Accepted: 10/17/2017] [Indexed: 12/25/2022] Open
Abstract
This study describes two longitudinal serological surveys of European Bat Lyssavirus type 1 (EBLV-1) antibodies in serotine bat (Eptesicus serotinus) maternity colonies located in the North-East of France. This species is currently considered as the main EBLV-1 reservoir. Multievent capture-recapture models were used to determine the factors influencing bat rabies transmission as this method accounts for imperfect detection and uncertainty in disease states. Considering the period of study, analyses revealed that survival and recapture probabilities were not affected by the serological status of individuals, confirming the capacity of bats to be exposed to lyssaviruses without dying. Five bats have been found with EBLV-1 RNA in the saliva at the start of the study, suggesting they were caught during virus excretion period. Among these bats, one was interestingly recaptured one year later and harbored a seropositive status. Along the survey, some others bats have been observed to both seroconvert (i.e. move from a negative to a positive serological status) and serorevert (i.e. move from a positive to a negative serological status). Peak of seroprevalence reached 34% and 70% in site A and B respectively. On one of the 2 sites, global decrease of seroprevalence was observed all along the study period nuanced by oscillation intervals of approximately 2-3 years supporting the oscillation infection dynamics hypothesized during a previous EBLV-1 study in a Myotis myotis colony. Seroprevalence were affected by significantly higher seroprevalence in summer than in spring. The maximum time observed between successive positive serological statuses of a bat demonstrated the potential persistence of neutralizing antibodies for at least 4 years. At last, EBLV-1 serological status transitions have been shown driven by age category with higher seroreversion frequencies in adults than in juvenile. Juveniles and female adults seemed indeed acting as distinct drivers of the rabies virus dynamics, hypothesis have been addressed but their exact role in the EBLV-1 transmission still need to be specified.
Collapse
Affiliation(s)
- Emmanuelle Robardet
- ANSES, Nancy Laboratory for Rabies and Wildlife–WHO Collaborating Centre for Research and Management in Zoonoses Control, OIE Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies Serology—Bâtiment H, Technopôle Agricole et Vétérinaire, CS, France
| | | | - Marie Moinet
- ANSES, Nancy Laboratory for Rabies and Wildlife–WHO Collaborating Centre for Research and Management in Zoonoses Control, OIE Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies Serology—Bâtiment H, Technopôle Agricole et Vétérinaire, CS, France
| | | | - Marine Wasniewski
- ANSES, Nancy Laboratory for Rabies and Wildlife–WHO Collaborating Centre for Research and Management in Zoonoses Control, OIE Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies Serology—Bâtiment H, Technopôle Agricole et Vétérinaire, CS, France
| | - Jacques Barrat
- ANSES, Nancy Laboratory for Rabies and Wildlife–WHO Collaborating Centre for Research and Management in Zoonoses Control, OIE Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies Serology—Bâtiment H, Technopôle Agricole et Vétérinaire, CS, France
| | - Franck Boué
- ANSES, Nancy Laboratory for Rabies and Wildlife–WHO Collaborating Centre for Research and Management in Zoonoses Control, OIE Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies Serology—Bâtiment H, Technopôle Agricole et Vétérinaire, CS, France
| | - Elodie Montchâtre-Leroy
- ANSES, Nancy Laboratory for Rabies and Wildlife–WHO Collaborating Centre for Research and Management in Zoonoses Control, OIE Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies Serology—Bâtiment H, Technopôle Agricole et Vétérinaire, CS, France
| | - Alexandre Servat
- ANSES, Nancy Laboratory for Rabies and Wildlife–WHO Collaborating Centre for Research and Management in Zoonoses Control, OIE Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies Serology—Bâtiment H, Technopôle Agricole et Vétérinaire, CS, France
| | - Olivier Gimenez
- CEFE UMR 5175, CNRS, Université de Montpellier, Université Paul-Valéry Montpellier, EPHE, France
| | - Florence Cliquet
- ANSES, Nancy Laboratory for Rabies and Wildlife–WHO Collaborating Centre for Research and Management in Zoonoses Control, OIE Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies Serology—Bâtiment H, Technopôle Agricole et Vétérinaire, CS, France
| | - Evelyne Picard-Meyer
- ANSES, Nancy Laboratory for Rabies and Wildlife–WHO Collaborating Centre for Research and Management in Zoonoses Control, OIE Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies Serology—Bâtiment H, Technopôle Agricole et Vétérinaire, CS, France
| |
Collapse
|
7
|
Nokireki T, Jakava-Viljanen M, Virtala AM, Sihvonen L. Efficacy of rabies vaccines in dogs and cats and protection in a mouse model against European bat lyssavirus type 2. Acta Vet Scand 2017; 59:64. [PMID: 28969696 PMCID: PMC5625686 DOI: 10.1186/s13028-017-0332-x] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2017] [Accepted: 09/24/2017] [Indexed: 12/25/2022] Open
Abstract
BACKGROUND Rabies is preventable by pre- and/or post-exposure prophylaxis consisting of series of rabies vaccinations and in some cases the use of immunoglobulins. The success of vaccination can be estimated either by measuring virus neutralising antibodies or by challenge experiment. Vaccines based on rabies virus offer cross-protection against other lyssaviruses closely related to rabies virus. The aim was to assess the success of rabies vaccination measured by the antibody response in dogs (n = 10,071) and cats (n = 722), as well as to investigate the factors influencing the response to vaccination when animals failed to reach a rabies antibody titre of ≥ 0.5 IU/ml. Another aim was to assess the level of protection afforded by a commercial veterinary rabies vaccine against intracerebral challenge in mice with European bat lyssavirus type 2 (EBLV-2) and classical rabies virus (RABV), and to compare this with the protection offered by a vaccine for humans. RESULTS A significantly higher proportion of dogs (10.7%, 95% confidence interval CI 10.1-11.3) than cats (3.5%; 95% CI 2.3-5.0) had a vaccination antibody titre of < 0.5 IU/ml. In dogs, vaccination with certain vaccines, vaccination over 6 months prior the time of antibody determination and vaccination of dogs with a size of > 60 cm or larger resulted in a higher risk of failing to reach an antibody level of at least 0.5 IU/ml. When challenged with EBLV-2 and RABV, 80 and 100% of mice vaccinated with the veterinary rabies vaccine survived, respectively. When mice were vaccinated with the human rabies vaccine and challenged with EBLV-2, 75-80% survived, depending on the booster. All vaccinated mice developed sufficient to high titres of virus-neutralising antibodies (VNA) against RABV 21-22 days post-vaccination, ranging from 0.5 to 128 IU/ml. However, there was significant difference between antibody titres after vaccinating once in comparison to vaccinating twice (P < 0.05). CONCLUSIONS There was a significant difference between dogs and cats in their ability to reach a post vaccination antibody titre of ≥ 0.5 IU/ml. Mice vaccinated with RABV-based rabies vaccines were partly cross-protected against EBLV-2, but there was no clear correlation between VNA titres and cross-protection against EBLV-2. Measurement of the RABV VNA titre can only be seen as a partial tool to estimate the cross-protection against other lyssaviruses. Booster vaccination is recommended for dogs and cats if exposed to infected bats.
Collapse
Affiliation(s)
- Tiina Nokireki
- Finnish Food Safety Authority Evira, Mustialankatu 3, 00790 Helsinki, Finland
| | | | - Anna-Maija Virtala
- Department of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki, P.O. Box 66, 00014 Helsinki, Finland
| | - Liisa Sihvonen
- Finnish Food Safety Authority Evira, Mustialankatu 3, 00790 Helsinki, Finland
- Department of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki, P.O. Box 66, 00014 Helsinki, Finland
| |
Collapse
|
8
|
Moldal T, Vikøren T, Cliquet F, Marston DA, van der Kooij J, Madslien K, Ørpetveit I. First detection of European bat lyssavirus type 2 (EBLV-2) in Norway. BMC Vet Res 2017; 13:216. [PMID: 28693578 PMCID: PMC5504624 DOI: 10.1186/s12917-017-1135-z] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2016] [Accepted: 06/28/2017] [Indexed: 12/25/2022] Open
Abstract
BACKGROUND In Europe, bat rabies is primarily attributed to European bat lyssavirus type 1 (EBLV-1) and European bat lyssavirus type 2 (EBLV-2) which are both strongly host-specific. Approximately thirty cases of infection with EBLV-2 in Daubenton's bats (Myotis daubentonii) and pond bats (M. dasycneme) have been reported. Two human cases of rabies caused by EBLV-2 have also been confirmed during the last thirty years, while natural spill-over to other non-flying mammals has never been reported. Rabies has never been diagnosed in mainland Norway previously. CASE PRESENTATION In late September 2015, a subadult male Daubenton's bat was found in a poor condition 800 m above sea level in the southern part of Norway. The bat was brought to the national Bat Care Centre where it eventually displayed signs of neurological disease and died after two days. EBLV-2 was detected in brain tissues by polymerase chain reaction (PCR) followed by sequencing of a part of the nucleoprotein gene, and lyssavirus was isolated in neuroblastoma cells. CONCLUSIONS The detection of EBLV-2 in a bat in Norway broadens the knowledge on the occurrence of this zoonotic agent. Since Norway is considered free of rabies, adequate information to the general public regarding the possibility of human cases of bat-associated rabies should be given. No extensive surveillance of lyssavirus infections in bats has been conducted in the country, and a passive surveillance network to assess rabies prevalence and bat epidemiology is highly desired.
Collapse
Affiliation(s)
- Torfinn Moldal
- Norwegian Veterinary Institute, Postbox 750, Sentrum, 0106 Oslo, Norway
| | - Turid Vikøren
- Norwegian Veterinary Institute, Postbox 750, Sentrum, 0106 Oslo, Norway
| | - Florence Cliquet
- Nancy OIE/WHO/EU Laboratory for Rabies and Wildlife, French Agency for Food, Environmental and Occupational Health & Safety, CS 40009, 54220 Malzéville, France
| | - Denise A. Marston
- Animal and Plant Health Agency, New Haw, Addlestone, Surrey KT15 3NB UK
| | - Jeroen van der Kooij
- Norwegian Zoological Society’s Bat Care Centre, Rudsteinveien 67, 1480 Slattum, Norway
| | - Knut Madslien
- Norwegian Veterinary Institute, Postbox 750, Sentrum, 0106 Oslo, Norway
| | - Irene Ørpetveit
- Norwegian Veterinary Institute, Postbox 750, Sentrum, 0106 Oslo, Norway
| |
Collapse
|
9
|
Müller T, Freuling CM, Wysocki P, Roumiantzeff M, Freney J, Mettenleiter TC, Vos A. Terrestrial rabies control in the European Union: historical achievements and challenges ahead. Vet J 2014; 203:10-7. [PMID: 25466578 DOI: 10.1016/j.tvjl.2014.10.026] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2014] [Revised: 10/15/2014] [Accepted: 10/20/2014] [Indexed: 12/25/2022]
Abstract
Due to the implementation of oral rabies vaccination (ORV) programmes, the European Union (EU) is becoming progressively free of red fox (Vulpes vulpes)-mediated rabies. Over the past three decades, the incidence of rabies had decreased substantially and vast areas of Western and Central Europe have been freed from rabies using this method of controlling an infectious disease in wildlife. Since rabies control is a top priority in the EU, the disease is expected to be eliminated from the animal source in the near future. While responsible authorities may consider the mission of eliminating fox rabies from the EU almost accomplished, there are still issues to be dealt with and challenges to be met that have not yet been in the focus of attention, but could jeopardise the ultimate goal. Among them are increasing illegal movements of animals, maintaining funding support for vaccination campaigns, devising alternative vaccine strategies in neighbouring Eastern European countries and the expanding distribution range of several potential rabies reservoir species in Europe.
Collapse
Affiliation(s)
- Thomas Müller
- Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler Institut, WHO Collaborating Centre for Rabies Surveillance and Research, OIE Reference Laboratory for Rabies, 17493 Greifswald-Insel Riems, Germany.
| | - Conrad Martin Freuling
- Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler Institut, WHO Collaborating Centre for Rabies Surveillance and Research, OIE Reference Laboratory for Rabies, 17493 Greifswald-Insel Riems, Germany
| | - Patrick Wysocki
- Institute of Epidemiology, Friedrich-Loeffler-Institut, 17493 Greifswald-Insel Riems, Germany
| | | | - Jean Freney
- Laboratoire de Microbiologie, Centre de Biologie et Pathologie Est Groupe de Recherche, Hospices Civils de Lyon & «Bactéries pathogènes opportunistes et environnement», UMR 5557 CNRS-UCBL, ISPB, Université Claude Bernard Lyon 1, Université de Lyon, France
| | - Thomas Christoph Mettenleiter
- Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler Institut, WHO Collaborating Centre for Rabies Surveillance and Research, OIE Reference Laboratory for Rabies, 17493 Greifswald-Insel Riems, Germany
| | - Adriaan Vos
- IDT Biologika GmbH, 06861 Dessau-Rosslau, Germany
| |
Collapse
|
10
|
Australian bat lyssavirus infection in two horses. Vet Microbiol 2014; 173:224-31. [PMID: 25195190 DOI: 10.1016/j.vetmic.2014.07.029] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2014] [Revised: 07/11/2014] [Accepted: 07/27/2014] [Indexed: 12/25/2022]
Abstract
In May 2013, the first cases of Australian bat lyssavirus infections in domestic animals were identified in Australia. Two horses (filly-H1 and gelding-H2) were infected with the Yellow-bellied sheathtail bat (YBST) variant of Australian bat lyssavirus (ABLV). The horses presented with neurological signs, pyrexia and progressing ataxia. Intra-cytoplasmic inclusion bodies (Negri bodies) were detected in some Purkinje neurons in haematoxylin and eosin (H&E) stained sections from the brain of one of the two infected horses (H2) by histological examination. A morphological diagnosis of sub-acute moderate non-suppurative, predominantly angiocentric, meningo-encephalomyelitis of viral aetiology was made. The presumptive diagnosis of ABLV infection was confirmed by the positive testing of the affected brain tissue from (H2) in a range of laboratory tests including fluorescent antibody test (FAT) and real-time PCR targeting the nucleocapsid (N) gene. Retrospective testing of the oral swab from (H1) in the real-time PCR also returned a positive result. The FAT and immunohistochemistry (IHC) revealed an abundance of ABLV antigen throughout the examined brain sections. ABLV was isolated from the brain (H2) and oral swab/saliva (H1) in the neuroblastoma cell line (MNA). Alignment of the genome sequence revealed a 97.7% identity with the YBST ABLV strain.
Collapse
|
11
|
Banyard AC, Healy DM, Brookes SM, Voller K, Hicks DJ, Núñez A, Fooks AR. Lyssavirus infection: 'low dose, multiple exposure' in the mouse model. Virus Res 2013; 181:35-42. [PMID: 24380842 DOI: 10.1016/j.virusres.2013.12.029] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2013] [Revised: 12/19/2013] [Accepted: 12/20/2013] [Indexed: 12/25/2022]
Abstract
The European bat lyssaviruses (EBLV-1 and EBLV-2) are zoonotic pathogens present within bat populations across Europe. The maintenance and transmission of lyssaviruses within bat colonies is poorly understood. Cases of repeated isolation of lyssaviruses from bat roosts have raised questions regarding the maintenance and intraspecies transmissibility of these viruses within colonies. Furthermore, the significance of seropositive bats in colonies remains unclear. Due to the protected nature of European bat species, and hence restrictions to working with the natural host for lyssaviruses, this study analysed the outcome following repeat inoculation of low doses of lyssaviruses in a murine model. A standardized dose of virus, EBLV-1, EBLV-2 or a 'street strain' of rabies (RABV), was administered via a peripheral route to attempt to mimic what is hypothesized as natural infection. Each mouse (n=10/virus/group/dilution) received four inoculations, two doses in each footpad over a period of four months, alternating footpad with each inoculation. Mice were tail bled between inoculations to evaluate antibody responses to infection. Mice succumbed to infection after each inoculation with 26.6% of mice developing clinical disease following the initial exposure across all dilutions (RABV, 32.5% (n=13/40); EBLV-1, 35% (n=13/40); EBLV-2, 12.5% (n=5/40)). Interestingly, the lowest dose caused clinical disease in some mice upon first exposure ((RABV, 20% (n=2/10) after first inoculation; RABV, 12.5% (n=1/8) after second inoculation; EBLV-2, 10% (n=1/10) after primary inoculation). Furthermore, five mice developed clinical disease following the second exposure to live virus (RABV, n=1; EBLV-1, n=1; EBLV-2, n=3) although histopathological examination indicated that the primary inoculation was the most probably cause of death due to levels of inflammation and virus antigen distribution observed. All the remaining mice (RABV, n=26; EBLV-1, n=26; EBLV-2, n=29) survived the tertiary and quaternary inoculations although the serological response did not necessarily reflect the repeated exposure. We conclude that despite repeated exposure, neither clinical disease nor serological response can be predicted and that further studies are required to understand the mechanisms behind survival following multiple exposures to lyssaviruses.
Collapse
Affiliation(s)
- Ashley C Banyard
- Wildlife Zoonoses and Vector Borne Diseases Research Group, Animal Health and Veterinary Laboratories Agency, Woodham Lane, New Haw, Surrey KT15 3NB, United Kingdom.
| | - Derek M Healy
- Wildlife Zoonoses and Vector Borne Diseases Research Group, Animal Health and Veterinary Laboratories Agency, Woodham Lane, New Haw, Surrey KT15 3NB, United Kingdom
| | - Sharon M Brookes
- Wildlife Zoonoses and Vector Borne Diseases Research Group, Animal Health and Veterinary Laboratories Agency, Woodham Lane, New Haw, Surrey KT15 3NB, United Kingdom
| | - Katja Voller
- Wildlife Zoonoses and Vector Borne Diseases Research Group, Animal Health and Veterinary Laboratories Agency, Woodham Lane, New Haw, Surrey KT15 3NB, United Kingdom
| | - Daniel J Hicks
- Pathology Unit, Department of Specialist Scientific Support, Animal Health and Veterinary Laboratories Agency, Woodham Lane, New Haw, Surrey KT15 3NB, United Kingdom
| | - Alejandro Núñez
- Pathology Unit, Department of Specialist Scientific Support, Animal Health and Veterinary Laboratories Agency, Woodham Lane, New Haw, Surrey KT15 3NB, United Kingdom
| | - Anthony R Fooks
- Wildlife Zoonoses and Vector Borne Diseases Research Group, Animal Health and Veterinary Laboratories Agency, Woodham Lane, New Haw, Surrey KT15 3NB, United Kingdom; Department of Clinical Infections, University of Liverpool, Microbiology and Immunology, United Kingdom
| |
Collapse
|
12
|
Vos A, Nolden T, Habla C, Finke S, Freuling CM, Teifke J, Müller T. Raccoons (Procyon lotor) in Germany as potential reservoir species for Lyssaviruses. EUR J WILDLIFE RES 2013. [DOI: 10.1007/s10344-013-0714-y] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
13
|
Abstract
The lyssaviruses are a diverse group of viruses capable of causing rabies, which is an invariably fatal encephalitic disease in both humans and animals. Currently, the lyssavirus genus consists of 12 species with 11 of these distinct species having been isolated from bats. The basis for the apparent geographical segregation of bat lyssavirus infection between the Old and New World is poorly understood. In the New World species of insectivorous, frugivorous, and hematophagous bats, all represent important reservoirs of rabies virus. In contrast, rabies virus has never been detected in Old World bat populations, despite being endemic in terrestrial mammals. Instead, both insectivorous and frugivorous bat species across the Old World appear to act as reservoirs for the non-rabies lyssaviruses. In this chapter, we describe the association of the different lyssaviruses with different bat species across the world, classifying bat species by their feeding behavior.
Collapse
Affiliation(s)
- Ashley C. Banyard
- Wildlife Zoonoses and Vector Borne Diseases Research Group, Department of Virology, Animal Health and Veterinary Laboratories Agency, Weybridge, New Haw, Addlestone, Surrey, KT15 3NB, UK
| | - David T.S. Hayman
- Wildlife Zoonoses and Vector Borne Diseases Research Group, Department of Virology, Animal Health and Veterinary Laboratories Agency, Weybridge, New Haw, Addlestone, Surrey, KT15 3NB, UK,Cambridge Infectious Diseases Consortium, Department of Veterinary Medicine, Madingley Road, Cambridge, CB3 0ES, UK,Department of Biology, Colorado State University, Fort Collins, CO 80523, USA
| | - Conrad M. Freuling
- Institute of Molecular Biology, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, D-17493 Greifswald - Insel Riems, Germany
| | - Thomas Müller
- Institute of Molecular Biology, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, D-17493 Greifswald - Insel Riems, Germany
| | - Anthony R. Fooks
- Wildlife Zoonoses and Vector Borne Diseases Research Group, Department of Virology, Animal Health and Veterinary Laboratories Agency, Weybridge, New Haw, Addlestone, Surrey, KT15 3NB, UK,National Consortium for Zoonosis Research, University of Liverpool, Leahurst, Chester High Road, Neston, Wirral, CH64 7TE, UK
| | - Nicholas Johnson
- Wildlife Zoonoses and Vector Borne Diseases Research Group, Department of Virology, Animal Health and Veterinary Laboratories Agency, Weybridge, New Haw, Addlestone, Surrey, KT15 3NB, UK
| |
Collapse
|
14
|
Racey PA, Hutson AM, Lina PHC. Bat rabies, public health and European bat conservation. Zoonoses Public Health 2012; 60:58-68. [PMID: 22909028 DOI: 10.1111/j.1863-2378.2012.01533.x] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Most records of European bat lyssaviruses (EBLVs) are confined to three species - the serotine bat for EBLV1 (900 records) and Daubenton's bat and the pond bat for EBLV2 (25 records). High levels of seroprevalence, which may vary from year to year, are also recorded. All bat vectors of EBLVs are synanthropic, some exclusively so. Despite this, there have been only five cases of human rabies resulting from EBLV infection in the 590 million people of greater Europe during the last 35 years. These have triggered major programmes of surveillance in many European countries. The emphasis on active versus passive surveillance and the intensity with which they have been carried out has varied from country to country. Both involve cooperation between bat researchers, virologists and public health officials and the latter, in particular, engages amateur bat workers and members of the public. Bat NGOs throughout Europe have worked to persuade the public not to handle bats or to do so only with gloved hands and, in the case of bat workers, to receive pre-exposure immunization. They have also countered negative media coverage of bat rabies. Householders with bat roosts in their dwellings have in general been persuaded to retain their bats. Attempts have been made to persuade all European countries to establish comparable EBLV surveillance programmes. In the last 25 years, virologists, public health officials, bat biologists and conservationists, both amateur and professional have worked closely and collaboratively for the protection of the public and the conservation of bats, with little polarization of views.
Collapse
Affiliation(s)
- P A Racey
- Centre for Conservation and Ecology, University of Exeter in Cornwall, Tremough, UK.
| | | | | |
Collapse
|
15
|
Abstract
Numerous bat species have been identified as important reservoirs of zoonotic viral pathogens. Rabies and rabies-related viruses constitute one of the most important viral zoonoses and pose a significant threat to public health across the globe. Whereas rabies virus (RABV) appears to be restricted to bats of the New World, related lyssavirus species have not been detected in the Americas and have only been detected in bat populations across Africa, Eurasia, and Australia. Currently, 11 distinct species of lyssavirus have been identified, 10 of which have been isolated from bat species and all of which appear to be able to cause encephalitis consistent with that seen with RABV infection of humans. In contrast, whereas lyssaviruses are apparently able to cause clinical disease in bats, it appears that these lyssaviruses may also be able to circulate within bat populations in the absence of clinical disease. This feature of these highly encephalitic viruses, alongside many other aspects of lyssavirus infection in bats, is poorly understood. Here, we review what is known of the complex relationship between bats and lyssaviruses, detailing both natural and experimental infections of these viruses in both chiropteran and nonchiropteran models. We also discuss potential mechanisms of virus excretion, transmission both to conspecifics and spill-over of virus into nonvolant species, and mechanisms of maintenance within bat populations. Importantly, we review the significance of neutralizing antibodies reported within bat populations and discuss the potential mechanisms by which highly neurovirulent viruses such as the lyssaviruses are able to infect bat species in the absence of clinical disease.
Collapse
Affiliation(s)
- Ashley C Banyard
- Rabies and Wildlife Zoonoses Group, Department of Virology, Veterinary Laboratories Agency, Weybridge, New Haw, Addlestone, Surrey, United Kingdom
| | | | | | | | | |
Collapse
|
16
|
Dagleish M, Benavides J, Chianini F. Immunohistochemical diagnosis of infectious diseases of sheep. Small Rumin Res 2010. [DOI: 10.1016/j.smallrumres.2010.04.003] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
17
|
Orbanz J, Finke S. Generation of recombinant European bat lyssavirus type 1 and inter-genotypic compatibility of lyssavirus genotype 1 and 5 antigenome promoters. Arch Virol 2010; 155:1631-41. [PMID: 20614145 DOI: 10.1007/s00705-010-0743-8] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2010] [Accepted: 06/25/2010] [Indexed: 12/25/2022]
Abstract
Bat lyssaviruses (Fam. Rhabdoviridae) represent a source for the infection of terrestial mammals and the development of rabies disease. Molecular differences in the replication of bat and non-bat lyssaviruses and their contribution to pathogenicity, however, are unknown. One reason for this is the lack of reverse genetics systems for bat-restricted lyssaviruses. To investigate bat lyssavirus replication and host adaptation, we developed a reverse genetics system for European bat lyssavirus type 1 (EBLV-1; genotype 5). This was achieved by co-transfection of HEK-293T cells with a full-length EBLV-1 genome cDNA and expression plasmids for EBLV-1 proteins, resulting in recombinant EBLV-1 (rEBLV-1). Replication of rEBLV-1 was comparable to that of parental virus, showing that rEBLV-1 is a valid tool to investigate EBLV-1 replication functions. In a first approach, we tested whether the terminal promoter sequences of EBLV-1 are genotype-specific. Although genotype 1 (rabies virus) minigenomes were successfully amplified by EBLV-1 helper virus, in the context of the complete virus, only the antigenome promoter (AGP) sequence of EBLV-1 was replaceable, as indicated by comparable replication of rEBLV-1 and the chimeric virus. These analyses demonstrate that the terminal AGPs of genotype 1 and genotype 5 lyssaviruses are compatible with those of the heterologous genotype.
Collapse
Affiliation(s)
- Jeannette Orbanz
- Friedrich-Loeffler-Institut, Federal Research Institut for Animal Health, Institute of Molecular Biology, Greifswald, Insel Riems, Germany
| | | |
Collapse
|
18
|
Intergenotypic replacement of lyssavirus matrix proteins demonstrates the role of lyssavirus M proteins in intracellular virus accumulation. J Virol 2009; 84:1816-27. [PMID: 19955305 DOI: 10.1128/jvi.01665-09] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Abstract
Lyssavirus assembly depends on the matrix protein (M). We compared lyssavirus M proteins from different genotypes for their ability to support assembly and egress of genotype 1 rabies virus (RABV). Transcomplementation of M-deficient RABV with M from European bat lyssavirus (EBLV) types 1 and 2 reduced the release of infectious virus. Stable introduction of the heterogenotypic M proteins into RABV led to chimeric viruses with reduced virus release and intracellular accumulation of virus genomes. Although the chimeras indicated genotype-specific evolution of M, rapid selection of a compensatory mutant suggested conserved mechanisms of lyssavirus assembly and the requirement for only few adaptive mutations to fit the heterogenotypic M to a RABV backbone. Whereas the compensatory mutant replicated to similar infectious titers as RABV M-expressing virus, ultrastructural analysis revealed that both nonadapted EBLV M chimeras and the compensatory mutant differed from RABV M expressing viruses in the lack of intracellular viruslike structures that are enveloped and accumulate in cisterna of the degranulated and dilated rough endoplasmic reticulum compartment. Moreover, all viruses were able to bud at the plasma membrane. Since the lack of the intracellular viruslike structures correlated with the type of M protein but not with the efficiency of virus release, we hypothesize that the M proteins of EBLV-1 and RABV differ in their target membranes for virus assembly. Although the biological function of intracellular assembly and accumulation of viruslike structures in the endoplasmic reticulum remain unclear, the observed differences could contribute to diverse host tropism or pathogenicity.
Collapse
|